Exicure (XCUR)

• Market cap: $45.9M
• 1 day: -0.14%
• 5 days: 7.23%
• 1 month: -22.16%
• 3 months: -37.22%
• 6 months: -7.97%
• Year to date: -52.11%
• 1 year: 343.29%
• 5 years: -97.85%
• 10 years: -98.16%
• Sector: Healthcare
• Industry: Biotechnology

About: Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

Employees: 8

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

9% more funds holding

Funds holding: 11 [Q4 2024] → 12 (+1) [Q1 2025]

1% more capital invested

Capital invested by funds: $4.06M [Q4 2024] → $4.12M (+$57.2K) [Q1 2025]

6.29% less ownership

Funds ownership: 11.39% [Q4 2024] → 5.1% (-6.29%) [Q1 2025]